Jerusalem Pharmaceutical Co. Stock price Palestine Exchange
Equities
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- | 0.00% |
Sales 2021 | 46.23M 0 | Sales 2022 | 46.14M 0 | Capitalization | 59.04M 0 |
---|---|---|---|---|---|
Net income 2021 | 6M - | Net income 2022 | 7M - | EV / Sales 2021 | 1.04 x |
Net cash position 2021 | 2.86M 0 | Net cash position 2022 | 5.6M 0 | EV / Sales 2022 | 1.16 x |
P/E ratio 2021 |
7.72
x | P/E ratio 2022 |
8.23
x | Employees | - |
Yield 2021 |
4.24% | Yield 2022 |
4.57% | Free-Float | 36% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 13-06-30 | |
Mohammed Natour
DFI | Director of Finance/CFO | - | 20-02-29 |
Chief Tech/Sci/R&D Officer | - | 88-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 89 | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
+28.67% | 46.19B | |
+18.57% | 22.88B | |
+20.11% | 14.18B | |
-0.18% | 12.63B | |
+46.16% | 12.07B | |
-1.55% | 7.85B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+7.37% | 5.14B |
- Stock
- Equities
- Stock Jerusalem Pharmaceuticals Co. Ltd.
- Stock Jerusalem Pharmaceutical Co. - Palestine Exchange